Lv2
160 积分 2023-02-18 加入
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
11小时前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
1个月前
已完结
LGR5/mTORC2 axis regulates cellular metabolic plasticity to maintain tumorigenesis in hepatocellular carcinoma
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
1个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
2个月前
已完结
Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug‐coated balloon in a swine femoral artery model
2个月前
已完结
The Ranger drug-coated balloon: advances in drug-coated technology for treatment of femoropopliteal segment arterial disease
2个月前
已完结
Factors Associated With Early and Late Restenosis Following Drug-Coated Balloon Treatment for Patients With Femoropopliteal Lesions
3个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
3个月前
已完结
皖公网安备34019202002308
